The Health Policy Partnership
Acronym: HPP
General Information
Identification Code: 223430420230-66
Website: [object Object]
Entity Form: Privately owned limited company
Registration Category: Professional consultancies
Registration Date: 1/8/2016
Last Update: 12/19/2023
EP Accredited Number: 0
Mission & Interests
Goals: We are a specialist health policy consultancy. We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems. We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
Levels of Interest:
- european
- national
- global
- sub-national
Activities
Main EU Legislative Proposals: Public health and healthcare policy, specific focus in cardiovascular disease, cancer, heart failure,rare diseases and respiratory issues.
Communication Activities: SPEAK UP FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
‘Speak Up’ is a multi-stakeholder coalition between Global Allergy & Airways Patient Platform (GAAPP), International Federation of Aging (IFA), COPD Foundation, International Coalition of Respiratory Nurses (ICRN), International Pharmaceutical Federation (FIP), in 2023 it received funding from AstraZeneca, Roche, Sanofi and Regeneron. All partners contributed time and expertise to the coalition activities. The coalition aims to raise awareness and understanding of chronic obstructive pulmonary disease (COPD) amongst policymakers and healthcare decision-makers by amplifying the voices of patients, the COPD community, and the public. HPP are supporting Speak Up on a new policy initiative that aimed to drive policy prioritisation for COPD and ultimately push COPD higher on policy agendas. As part of the ongoing activities, in October 2023, HPP organised a workshop gathering policymakers, experts in COPD, and other relevant stakeholders to examine current barriers to greater awareness and policy prioritisation of COPD and explore how to make messages about COPD resonate with policymakers. Whilst MEPS were invited to participate in the workshop, none were able to attend. In 2024, HPP will be developing a global ‘State of COPD’ policy report which will assess the current policy landscape in COPD in key countries/regions and outline essential areas for future policy action.
HEART FAILURE POLICY NETWORK (HFPN)
HPP acts as Secretariat for HFPN, a multidisciplinary group of experts from across Europe working with patients, health professionals and other stakeholders to lead significant policy changes that may improve the lives of people with heart failure (HF). The HFPN has ongoing relationships with several MEPs who donate their time for free to support (and act as Members of) the HFPN. In 2023, HFPN initiated the European Heart Failure Mission which aimed to secure political recognition and investment for HF from the EU. In October 2023, HFPN launched a Mission Statement (a call to action to the EU) at an event at the European Parliament. The event, hosted by Billy Kelleher MEP and gathering together 50 members of the heart failure community from across Europe, kicked off a multi-year campaign to drive heart failure to the top of the political agenda. The EU Mission activities are funded by AstraZeneca and Roche Diagnostics.
LUNG CANCER IN EUROPE: ACCELERATING OPPORTUNITIES TO IMPROVE SURVIVAL
In November 2023, HPP organised a webinar entitled ‘Lung cancer in Europe: accelerating opportunities to improve survival’. The online event was attended by patient advocates, clinicians and researchers to discuss priorities for improving the early detection and treatment of lung cancer in Europe. Penilla Gunther from the European Cancer Organisation spoke in her role as part of the EU Cancer Mission Board. This event was funded by Johnson & Johnson NCB an affiliate of Johnson & Johnson. The Health Policy Partnership was engaged by Johnson & Johnson to organise and develop the event on its behalf. The webinar and associated outputs were non-promotional and evidence based and are created by The Health Policy Partnership on behalf of Johnson & Johnson NCB.
WILSON'S DISEASE POLICY NETWORK
HPP runs the Secretariat for the Wilson’s Disease Policy Network, in collaboration with its multi-stakeholder Steering Committee. All outputs are non-promotional, evidence based and shaped by the Steering Committee, which has editorial control. In 2023, HPP co-hosted an event with the European Liver Patient’s Association (ELPA) in Brussels. The event brought together patient advocates, healthcare professionals and policy experts in the field of Wilson’s Disease, and rare diseases more broadly, to discuss what can be done at the EU level to drive change. It was funded by Alexion.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: The Health Policy Partnership68-69 St Martin's Lane
Post Code: WC2N 4JS
City: London
Country: UNITED KINGDOM
Phone: [object Object]
EU Office
Address: The Health Policy Partnership68-69 St Martin's Lane
Post Code: WC2N 4JS
City: London
Country: UNITED KINGDOM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 12
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 12
Members F T E: 1.2000000476837158
Info Members: Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.
Structure
Structure Type: Structure
Is Member Of: Please see www.hfpolicynetwork.eu
Organisation Members: Heart Failure Policy Network - www.hfpolicynetwork.eu
(provide secretariat and lead project)